Ved graviditet skal methotrexat kun administreres på strenge indikationer, hvor fordelene ved behandlingen for moderen vurderes mod de mulige farer for fostret.
During pregnancy, methotrexate should only be administered on strict indications, where the benefits of the drug to the mother should be weighed against possible hazards to the foetus.